Rapport Therapeutics Inc (NASDAQ:RAPP) has seen 75763.0 shares traded in the last trading session. The company, currently valued at $581.62M, closed the last trade at $15.90 per share which meant it gained $0.13 on the day or 0.82% during that session. The RAPP stock price is -87.04% off its 52-week high price of $29.74 and 23.96% above the 52-week low of $12.09. If we look at the company’s 10-day average daily trading volume, we find that it stood at 95800.0 shares traded. The 3-month trading volume is 113.41K shares.
The consensus among analysts is that Rapport Therapeutics Inc (RAPP) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
Rapport Therapeutics Inc (NASDAQ:RAPP) trade information
Sporting 0.82% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the RAPP stock price touched $15.90 or saw a rise of 6.74%. Year-to-date, Rapport Therapeutics Inc shares have moved -10.37%, while the 5-day performance has seen it change -1.43%. Over the past 30 days, the shares of Rapport Therapeutics Inc (NASDAQ:RAPP) have changed 19.19%. Short interest in the company has seen 1.51 million shares shorted with days to cover at 14.97.
Wall Street analysts have a consensus price target for the stock at $35, which means that the shares’ value could jump 54.57% from current levels. The projected low price target is $35.0 while the price target rests at a high of $35.0. In that case, then, we find that the current price level is -120.13% off the targeted high while a plunge would see the stock gain -120.13% from current levels.
RAPP Dividends
Rapport Therapeutics Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Rapport Therapeutics Inc (NASDAQ:RAPP)’s Major holders
Also the top two Mutual Funds that are holding company’s shares are Fidelity Growth Company Fund and Smallcap World Fund. As of Dec 31, 2024 , the former fund manager holds about 4.17% shares in the company for having 1.53 shares of worth $24.25 million while later fund manager owns 861.61 shares of worth $13.7 million as of Sep 30, 2024 , which makes it owner of about 2.36% of company’s outstanding stock.
